VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS46001147 | BKPyv | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS46001326 | BKPyv | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS42001156 | EBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10009443 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10009444 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10010334 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10007991 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10009525 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10010594 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
TVIS10012210 | HBV | ENSG00000172572.7 | protein_coding | PDE3A | No | No | 5139 | Q14432 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | PDE3A |
---|---|
DrugBank ID | DB00261 |
Drug Name | Anagrelide |
Target ID | BE0000436 |
UniProt ID | Q14432 |
Regulation Type | inhibitor |
PubMed IDs | 2846839; 31598394 |
Citations | Venuti MC, Stephenson RA, Alvarez R, Bruno JJ, Strosberg AM: Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline. J Med Chem. 1988 Nov;31(11):2136-45.@@An R, Liu J, He J, Wang F, Zhang Q, Yu Q: PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth. Am J Cancer Res. 2019 Sep 1;9(9):1905-1921. eCollection 2019. |
Groups | Approved |
Direct Classification | Quinazolines |
SMILES | ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl |
Pathways | |
PharmGKB | PA164742986 |
ChEMBL | CHEMBL760 |